FDA-cleared K173444
Quantitative Total Extensible Imaging (QTxI)
AIQ Solutions, Inc.
Authorized purpose: QTxI manages and evaluates supported DICOM CT and PET studies, including registration, fusion, region-of-interest contouring, quantitative analysis, and evaluation of quantitative changes in the labeled workflow.
- Modality
- Radiological images; modality varies or is not specified in FDA list
- Anatomy
- Multi-region
- Decision
- 2018-07-23